The correlation of the change of RANK/RANKL signaling pathway and metastatic carcinoma from solid cancers, such as breast cancer, could be studied by examining patient samples with both molecular and morphological technologies. The gene discussed is TNFRSF11A; the disease is breast carcinoma.